Neuropathologic basis of quantitative susceptibility mapping in the substantia nigra: contributions of tau, pigmented neurons, and iron - Top-Institutions - MDSpire

Neuropathologic basis of quantitative susceptibility mapping in the substantia nigra: contributions of tau, pigmented neurons, and iron

  • By

  • Daisuke Ono

  • Sravya Kondrakunta

  • Elijah Mak

  • Scott A. Przybelski

  • Angela J. Fought

  • Christopher G. Schwarz

  • Melissa E. Murray

  • Aivi Nguyen

  • Ross R. Reichard

  • Matthew L. Senjem

  • Jeffrey L. Gunter

  • Clifford R. Jack

  • Toji Miyagawa

  • Leah K. Forsberg

  • Julie A. Fields

  • Rodolfo Savica

  • Vijay K. Ramanan

  • David T. Jones

  • Hugo Botha

  • Erik K. St. Louis

  • David S. Knopman

  • Neill R. Graff-Radford

  • Gregory S. Day

  • Tanis J. Ferman

  • Walter K. Kremers

  • Val J. Lowe

  • Ronald C. Petersen

  • Bradley F. Boeve

  • Dennis W. Dickson

  • Kejal Kantarci

  • February 18, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neuroimaging
    • Neuropathology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Neuroimaging
    • Neuroscience

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Neuroimaging
    • Neuroscience

  • #4

    Massachusetts General Hospital (MGH) / Harvard Medical School
    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neurology
    • Radiology
    • Neuroimaging

Original Source(s)

Neuropathologic basis of quantitative susceptibility mapping in the substantia nigra: contributions of tau, pigmented neurons, and iron

  • by Daisuke Ono, Sravya Kondrakunta, Elijah Mak, Scott A. Przybelski, Angela J. Fought, Christopher G. Schwarz, Melissa E. Murray, Aivi Nguyen, Ross R. Reichard, Matthew L. Senjem, Jeffrey L. Gunter, Clifford R. Jack, Toji Miyagawa, Leah K. Forsberg, Julie A. Fields, Rodolfo Savica, Vijay K. Ramanan, David T. Jones, Hugo Botha, Erik K. St. Louis, David S. Knopman, Neill R. Graff-Radford, Gregory S. Day, Tanis J. Ferman, Walter K. Kremers, Val J. Lowe, Ronald C. Petersen, Bradley F. Boeve, Dennis W. Dickson, Kejal Kantarci

  • February 18, 2026

Related Content

Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degeneration

Baptist Health Miami Neuroscience Institute Advances Parkinson’s Disease Imaging With Specialized MRI Protocol

Diagnosing Parkinson’s disease has long depended primarily on clinical expertise — careful neurologic examination, longitudinal symptom assessment and the nuanced interpretation of movement abnormalities.

  • by

  • May 11, 2026

  • 5 min
Anti-diabetic medications to fight Parkinson's disease and dementia with Lewy bodies: a pilot study